Bone Therapeutics SA : Business Update for Third Quarter 2017

02:00 EST 9 Nov 2017 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Regulated information Bone Therapeutics Business Update for Third Quarter 2017 Strong interim results for ALLOB® Phase IIA spinal fusion trial All patients met primary endpoint in ALLOB® Phase I/IIA delayed-union study interim analys...

Other Sources for this Article


More From BioPortfolio on "Bone Therapeutics SA : Business Update for Third Quarter 2017"

Quick Search


Relevant Topics

Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...